Tilray Medical Announces Positive Results from Study on Oral Cannabis Extract for Chemotherapy-Induced Emesis
Tilray Medical, a division of ("Tilray Brands") (NASDAQ: TLRY and TSX: TLRY) and a global leader in medical cannabis empowering the therapeutic alliance between patients and healthcare practitioners ...
Tilray Launches "Men's Health on Tap" Podcast: Acclaimed Doctors Engage in Empowering Discussions and Break Down Stigmas Around Men's Health Topics
NEW YORK, Nov. 07, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: TLRY and TSX: TLRY), a lifestyle and consumer packaged goods company, ...
Election outcome
Real-time stock price for Tilray Inc (TLRY-T), along with buy or sell indicators, analysis, charts, historical performance, news and more ...
Tilray launches new podcast series to break down stigmas around men’s health
Brands announces the launch of “Men’s Health on Tap,” a new podcast series hosted by distinguished doctors, Dr.
Cannabis Extract Significantly Reduces Chemotherapy-Induced Vomiting, Tilray-Backed Study Reveals
On Thursday, Tilray Medical, a division of medical marijuana giant Tilray Brands, Inc. (NASDAQ:TLRY), announced the final ...
Canada stocks higher at close of trade; S&P/TSX Composite up 0.94%
Canada stocks were higher after the close on Wednesday, as gains in the IT, Energy and Industrials sectors led shares higher.
Cannabis stocks fall as Florida marijuana legalization fails
A ballot measure to legalize recreational marijuana failed in the state of Florida, driving a big blow to the cannabis ...
Tilray Brands Is Still Priced Too High
Q1 was way below expectations, and the outlook has been diminished. The stock looks expensive to peers. Find out why TLRY ...